{"id":944495,"date":"2026-03-14T08:03:03","date_gmt":"2026-03-14T12:03:03","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\/"},"modified":"2026-03-14T08:03:03","modified_gmt":"2026-03-14T12:03:03","slug":"holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\/","title":{"rendered":"Holzer & Holzer, LLC Reminds Investors of April 6, 2026 Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against BlackRock TCP Capital Corp. (TCPC), Mereo BioPharma Group plc (MREO), POMDOCTOR LIMITED (POM), and Ultragenyx Pharmaceutical Inc. (RARE)"},"content":{"rendered":"
\n

ATLANTA, March 14, 2026 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits:<\/p>\n

\n
\n BlackRock TCP Capital Corp. (TCPC)<\/u>
\n <\/strong>\n <\/p>\n

The shareholder class action lawsuit filed against BlackRock TCP Capital Corp. (\u201cBlackRock TCP\u201d) (NASDAQ: TCPC) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts including that BlackRock TCP\u2019s investments were not being timely and\/or appropriately valued between November 6, 2024 and January 23, 2026<\/strong>. If you purchased BlackRock TCP shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com<\/a>, by toll-free telephone at (888) 508-6832 or you may visit the firm\u2019s website at www.holzerlaw.com\/case\/blackrock-tcp-capital\/<\/a> to learn more.<\/p>\n

\n The deadline to ask the court to be appointed lead plaintiff in the case is\u00a0April 6, 2026.<\/strong>\n <\/p>\n

\n
\n Mereo BioPharma Group plc (MREO)<\/u>
\n <\/strong>\n <\/p>\n

The shareholder class action lawsuit filed against Mereo BioPharma Group plc (\u201cMereo\u201d) (NASDAQ: MREO) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts regarding setrusumab\u2019s ability to achieve statistical significance for the primary endpoints in both the ORBIT and COSMIC studies between June 5, 2023 and December 26, 2025<\/strong>. If you purchased Mereo shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com<\/a>, by toll-free telephone at (888) 508-6832 or you may visit the firm\u2019s website at www.holzerlaw.com\/case\/mereo-biopharma-group\/<\/a> to learn more.<\/p>\n

\n The deadline to ask the court to be appointed lead plaintiff in the case is\u00a0April 6, 2026.<\/strong>\n <\/p>\n

\n
\n POMDOCTOR LIMITED (POM)<\/u>
\n <\/strong>\n <\/p>\n

The shareholder class action lawsuit filed against POMDOCTOR LIMITED (\u201cPomdoctor\u201d) (NASDAQ: POM) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts regarding an alleged fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals between October 9, 2025 and December 11, 2025<\/strong>. If you purchased Pomdoctor shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com<\/a>, by toll-free telephone at (888) 508-6832 or you may visit the firm\u2019s website at www.holzerlaw.com\/case\/pomdoctor\/<\/a> to learn more.<\/p>\n

\n The deadline to ask the court to be appointed lead plaintiff in the case is April 6, 2026.<\/strong>\n <\/p>\n

\n
\n Ultragenyx Pharmaceutical Inc. (RARE)<\/u>
\n <\/strong>\n <\/p>\n

The shareholder class action lawsuit filed against Ultragenyx Pharmaceutical Inc. (\u201cUltragenyx\u201d) (NASDAQ: RARE) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts regarding Ultragenyx\u2019s expected results for its Phase III Orbit and Cosmic Studies between August 3, 2023 and December 26, 2025<\/strong>. If you purchased Ultragenyx shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com<\/a>, by toll-free telephone at (888) 508-6832 or you may visit the firm\u2019s website at www.holzerlaw.com\/case\/ultragenyx-pharmaceutical\/<\/a> to learn more.<\/p>\n

\n The deadline to ask the court to be appointed lead plaintiff in the case is\u00a0April 6, 2026.<\/strong>\n <\/p>\n

Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, 2023, and 2025, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct.\u202fMore information about the firm is available through its website, https:\/\/holzerlaw.com\/<\/a>,\u202fand upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.\u202f\u00a0<\/p>\n

CONTACT:
Corey Holzer, Esq.
(888) 508-6832 (toll-free)
cholzer@holzerlaw.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

ATLANTA, March 14, 2026 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: BlackRock TCP Capital Corp. (TCPC) The shareholder class action lawsuit filed against BlackRock TCP Capital Corp. (\u201cBlackRock TCP\u201d) (NASDAQ: TCPC) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts including that BlackRock TCP\u2019s investments were not being timely and\/or appropriately valued between November 6, 2024 and January 23, 2026. If you purchased BlackRock TCP shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free … <\/p>\n

Continue reading “Holzer & Holzer, LLC Reminds Investors of April 6, 2026 Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against BlackRock TCP Capital Corp. (TCPC), Mereo BioPharma Group plc (MREO), POMDOCTOR LIMITED (POM), and Ultragenyx Pharmaceutical Inc. (RARE)”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-944495","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nHolzer & Holzer, LLC Reminds Investors of April 6, 2026 Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against BlackRock TCP Capital Corp. (TCPC), Mereo BioPharma Group plc (MREO), POMDOCTOR LIMITED (POM), and Ultragenyx Pharmaceutical Inc. (RARE) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Holzer & Holzer, LLC Reminds Investors of April 6, 2026 Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against BlackRock TCP Capital Corp. (TCPC), Mereo BioPharma Group plc (MREO), POMDOCTOR LIMITED (POM), and Ultragenyx Pharmaceutical Inc. (RARE) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ATLANTA, March 14, 2026 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: BlackRock TCP Capital Corp. (TCPC) The shareholder class action lawsuit filed against BlackRock TCP Capital Corp. (\u201cBlackRock TCP\u201d) (NASDAQ: TCPC) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts including that BlackRock TCP\u2019s investments were not being timely and\/or appropriately valued between November 6, 2024 and January 23, 2026. If you purchased BlackRock TCP shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free … Continue reading "Holzer & Holzer, LLC Reminds Investors of April 6, 2026 Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against BlackRock TCP Capital Corp. (TCPC), Mereo BioPharma Group plc (MREO), POMDOCTOR LIMITED (POM), and Ultragenyx Pharmaceutical Inc. (RARE)"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-14T12:03:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY3MTg3MyM3NDg0OTU0IzIxODA3Njc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Holzer & Holzer, LLC Reminds Investors of April 6, 2026 Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against BlackRock TCP Capital Corp. (TCPC), Mereo BioPharma Group plc (MREO), POMDOCTOR LIMITED (POM), and Ultragenyx Pharmaceutical Inc. (RARE)\",\"datePublished\":\"2026-03-14T12:03:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\\\/\"},\"wordCount\":684,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY3MTg3MyM3NDg0OTU0IzIxODA3Njc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\\\/\",\"name\":\"Holzer & Holzer, LLC Reminds Investors of April 6, 2026 Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against BlackRock TCP Capital Corp. (TCPC), Mereo BioPharma Group plc (MREO), POMDOCTOR LIMITED (POM), and Ultragenyx Pharmaceutical Inc. (RARE) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY3MTg3MyM3NDg0OTU0IzIxODA3Njc=\",\"datePublished\":\"2026-03-14T12:03:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY3MTg3MyM3NDg0OTU0IzIxODA3Njc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY3MTg3MyM3NDg0OTU0IzIxODA3Njc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Holzer & Holzer, LLC Reminds Investors of April 6, 2026 Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against BlackRock TCP Capital Corp. (TCPC), Mereo BioPharma Group plc (MREO), POMDOCTOR LIMITED (POM), and Ultragenyx Pharmaceutical Inc. (RARE)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Holzer & Holzer, LLC Reminds Investors of April 6, 2026 Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against BlackRock TCP Capital Corp. (TCPC), Mereo BioPharma Group plc (MREO), POMDOCTOR LIMITED (POM), and Ultragenyx Pharmaceutical Inc. (RARE) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\/","og_locale":"en_US","og_type":"article","og_title":"Holzer & Holzer, LLC Reminds Investors of April 6, 2026 Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against BlackRock TCP Capital Corp. (TCPC), Mereo BioPharma Group plc (MREO), POMDOCTOR LIMITED (POM), and Ultragenyx Pharmaceutical Inc. (RARE) - Market Newsdesk","og_description":"ATLANTA, March 14, 2026 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: BlackRock TCP Capital Corp. (TCPC) The shareholder class action lawsuit filed against BlackRock TCP Capital Corp. (\u201cBlackRock TCP\u201d) (NASDAQ: TCPC) alleges that Defendants made materially false and\/or misleading statements and\/or failed to disclose material facts including that BlackRock TCP\u2019s investments were not being timely and\/or appropriately valued between November 6, 2024 and January 23, 2026. If you purchased BlackRock TCP shares during this time period and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free … Continue reading \"Holzer & Holzer, LLC Reminds Investors of April 6, 2026 Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against BlackRock TCP Capital Corp. (TCPC), Mereo BioPharma Group plc (MREO), POMDOCTOR LIMITED (POM), and Ultragenyx Pharmaceutical Inc. (RARE)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\/","og_site_name":"Market Newsdesk","article_published_time":"2026-03-14T12:03:03+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY3MTg3MyM3NDg0OTU0IzIxODA3Njc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Holzer & Holzer, LLC Reminds Investors of April 6, 2026 Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against BlackRock TCP Capital Corp. (TCPC), Mereo BioPharma Group plc (MREO), POMDOCTOR LIMITED (POM), and Ultragenyx Pharmaceutical Inc. (RARE)","datePublished":"2026-03-14T12:03:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\/"},"wordCount":684,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY3MTg3MyM3NDg0OTU0IzIxODA3Njc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\/","name":"Holzer & Holzer, LLC Reminds Investors of April 6, 2026 Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against BlackRock TCP Capital Corp. (TCPC), Mereo BioPharma Group plc (MREO), POMDOCTOR LIMITED (POM), and Ultragenyx Pharmaceutical Inc. (RARE) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY3MTg3MyM3NDg0OTU0IzIxODA3Njc=","datePublished":"2026-03-14T12:03:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY3MTg3MyM3NDg0OTU0IzIxODA3Njc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY3MTg3MyM3NDg0OTU0IzIxODA3Njc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/holzer-holzer-llc-reminds-investors-of-april-6-2026-lead-plaintiff-deadlines-in-shareholder-class-action-lawsuits-against-blackrock-tcp-capital-corp-tcpc-mereo-biopharma-group-plc-mreo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Holzer & Holzer, LLC Reminds Investors of April 6, 2026 Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against BlackRock TCP Capital Corp. (TCPC), Mereo BioPharma Group plc (MREO), POMDOCTOR LIMITED (POM), and Ultragenyx Pharmaceutical Inc. (RARE)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/944495","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=944495"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/944495\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=944495"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=944495"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=944495"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}